Spectrum of Pharmacological Effects
Benzodiazepine derivatives exhibit a wide range of activity depending on dosage and the site of action. The main pharmacological effects include:
- Anxiolytic: The drugs effectively relieve fear, internal anxiety, and severe mental tension. This reduction in emotional stress promotes general calming and creates a favorable background for the onset of physiological sleep.
- Sedative and Hypnotic: Relatively low doses produce a calming effect, which gradually transitions into a full hypnotic effect as the dose is increased.
- Myorelaxant (Muscle Relaxant): Pathologically increased skeletal muscle tone is reduced. This process is caused by the direct inhibition of nerve impulse transmission in polysynaptic reflex arcs at the spinal cord level.
- Anticonvulsant: Benzodiazepines suppress pathological seizure activity in the brain.
- Amnestic: A specific property of these drugs is the ability to induce anterograde amnesia, in which the patient temporarily loses memory of events occurring immediately after administration.
Localization of Action in the Nervous System
Pharmacodynamic effects are mediated through the targeted inhibition of specific anatomical structures within the central nervous system. The hypnotic and anxiolytic effects are primarily associated with actions on the limbic system, which is responsible for the formation and regulation of human emotions.
Additionally, the drugs affect the brainstem reticular formation. Normally, this structure acts as an ascending reticular activating system (ARAS) that maintains the cerebral cortex in an active state. Benzodiazepines reduce this ascending stimulatory influence, inevitably leading to cortical inhibition and facilitating sleep onset.
Receptors and the GABA-Benzodiazepine Complex
The primary target for this group of drugs is the specific benzodiazepine receptor (often designated in specialized literature as $\omega$-receptors). Several subtypes of these receptors exist: $\omega_1$, $\omega_2$, and $\omega_3$. Notably, the hypnotic effect is strongly linked to the preferential activation of $\omega_1$ receptors.
These receptors do not exist in isolation; they are a structural and functional part of the complex GABA-A ($GABA_A$) receptor complex.
The structure of the complex is as follows:
- The GABA-A receptor itself is a large glycoprotein forming an ionotropic chloride channel within the cell membrane.
- In terms of subunit composition, it is a pentamer (consisting of five subunits): two $\alpha$ subunits, two $\beta$ subunits, and one $\gamma$ subunit.
- Binding topography is strictly distributed: the endogenous inhibitory neurotransmitter GABA binds to the $\alpha$ and $\beta$ subunits, whereas benzodiazepine molecules bind exclusively to the $\gamma$ subunit.
Molecular Mechanism: From Binding to Inhibition
At the molecular and electrophysiological levels, the interaction of benzodiazepines with the receptor occurs via allosteric modulation. When a drug binds to its $\gamma$ subunit, it significantly increases the sensitivity of the entire complex to the neurotransmitter (GABA). As a result, the efficacy of natural endogenous GABA is markedly enhanced.
A crucial distinction of benzodiazepines is that they lack intrinsic agonist activity: they cannot open the ion channel independently without the presence of GABA. This explains the absence of direct narcotic action, which is characteristic of substances that can open chloride channels directly without a neurotransmitter.
Electrophysiological Outcome:
- The frequency of chloride channel opening increases.
- A massive influx of negatively charged chloride ions ($Cl^-$) enters the neuron.
- Profound hyperpolarization of the neuronal membrane develops.
- The net result is powerful central nervous system inhibition.
Additionally, benzodiazepines enter into pharmacodynamic interactions with other substances. Specifically, they potentiate the effects of any CNS depressants, including ethanol and general anesthetics.